Skretting and Proteon to trial bacteriophages for aquaculture

  30 January 2021

Skretting and Proteon Pharmaceuticals are co-developing products using bacteriophages to support fish farmers as part of a holistic health strategy.

The companies will work in a parallel R&D pipeline for the project to target pathogenic bacteria. With bacterial challenges being some of the most prevalent in aquaculture worldwide, the products will be a welcome addition to the holistic health toolbox for farmers.


Further reading: The Fish Site
Author(s): The Fish Site
Healthy Animals   Secure Foods  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!